RBMY is reportedly increased mainly in the hepatic stem cells of patients with HCC where it aberrantly signals GSK3β-WNT-β catenin signaling complex resulting in cell proliferation [124]. Here, RBMY1A1 is linked to hepatocellular carcinoma.